Stay updated on Lorlatinib Combos in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib Combos in Lung Cancer Clinical Trial page.

Latest updates to the Lorlatinib Combos in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe site revision indicator changed from v3.7.2 to v3.8.0; the study record itself is unchanged.SummaryDifference0.1%

- Check23 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record details remain unchanged.SummaryDifference0.8%

- Check30 days agoChange DetectedThe ClinicalTrials.gov site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history adds a new site revision entry, 'Revision: v3.7.0', replacing the previous 'Revision: v3.6.6' in the version log.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry, v3.6.6, was added to the study record history, indicating the page was updated to the latest release version. This reflects a maintenance update to the record rather than changes to trial content or eligibility.SummaryDifference0.1%

Stay in the know with updates to Lorlatinib Combos in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib Combos in Lung Cancer Clinical Trial page.